There are two putative PLP1-related MS mechanisms: PLP1 mutations could damage oligodendrocytes [39], generating an inside-out disease process, or they could cause the expression of neoantigens that the immune system could target [14]. The gene discussed is PLP1; the disease is myeloid sarcoma.